Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

APOL1 Genetic Testing Program for Living Donors, Part 2

NCT04999436 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT04999436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04999436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
APOL1 Genetic Testing Program for Living Donors, Part 2
Lead sponsor
Northwestern University
Phase
Not applicable
Overall status
Completed
Start date
July 19, 2022
Completion date
January 27, 2025
Enrollment
35 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, genetic predisposition